Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name JNJ-64457107
Trade Name
Synonyms ADC-1013|Mitazalimab|JNJ 7107
Drug Descriptions

JNJ-64457107 (mitazalimab) is a CD40 agonist that may lead to a T-cell dependent antitumor response, potentially inducing in tumor growth inhibition (PMID: 25316820, PMID: 30664811).

DrugClasses CD40 Antibody 13
CAS Registry Number 2055640-86-1
NCIT ID C121538

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Fluorouracil + Irinotecan + JNJ-64457107 + Leucovorin + Oxaliplatin Fluorouracil Irinotecan JNJ-64457107 Leucovorin Oxaliplatin 0 1
JNJ-64457107 JNJ-64457107 0 1


Additional content available in CKB BOOST